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The nonsense-mediated mRNA decay (NMD) pathway has historically been thought of as an RNA surveillance system that degrades mRNAs with premature translation termination codons, but the NMD pathway of
Saccharomyces cerevisiae has a second role regulating the decay of some wild-type mRNAs. In S. cerevisiae, a
significant number of wild-type mRNAs are affected when NMD is inactivated. These mRNAs are either
wild-type NMD substrates or mRNAs whose abundance increases as an indirect consequence of NMD. A
current challenge is to sort the mRNAs that accumulate when NMD is inactivated into direct and indirect
targets. We have developed a bioinformatics-based approach to address this challenge. Our approach involves
using existing genomic and function databases to identify transcription factors whose mRNAs are elevated in
NMD-deficient cells and the genes that they regulate. Using this strategy, we have investigated a coregulated
set of genes. We have shown that NMD regulates accumulation of ADR1 and GAL4 mRNAs, which encode
transcription activators, and that Adr1 is probably a transcription activator of ATS1. This regulation is
physiologically significant because overexpression of ADR1 causes a respiratory defect that mimics the defect
seen in strains with an inactive NMD pathway. This strategy is significant because it allows us to classify the
genes regulated by NMD into functionally related sets, an important step toward understanding the role NMD
plays in the normal functioning of yeast cells.
Ppr1 as an indirect consequence of inactivation of the NMD
pathway. To date, a limited number of natural NMD substrates
have been identified. In addition to PPR1 mRNA, 12 wild-type
mRNAs that are degraded by the NMD pathway have been
identified (15, 20, 37, 41). Given the number of mRNAs that are
affected by inactivation of the NMD pathway, it is very likely that
additional wild-type mRNAs are direct NMD substrates.
The number of direct versus indirect NMD substrates in S.
cerevisiae is controversial. Lelivelt and Culbertson (28) measured the half-lives of nine mRNAs whose abundance was
increased in NMD mutants. None of these mRNAs has an
altered half-life. This suggests that the majority of mRNAs that
accumulate in NMD mutants may be indirect targets. He et al.
(15) argue, on the other hand, that the majority of mRNAs that
accumulate when NMD is inactivated are direct substrates. To
resolve this controversy, it is important to identify direct versus
indirect NMD substrates. This could be done by determining
the mRNA half-lives of all of the potential NMD substrates in
wild-type and NMD-deficient cells by using microarrays. However, this approach will miss low-abundance mRNAs, like
PPR1 mRNA, that are below the threshold of detection (28).
We have developed a complementary bioinformatics-based approach. Our approach involves using existing genomic and
function databases to identify transcription factors whose
mRNAs are elevated in NMD-deficient cells and the genes
that they regulate. Using this strategy, we have investigated a
coregulated set of genes. We have shown that NMD regulates
accumulation of ADR1 mRNA, which encodes a transcription
activator of genes for generation of acetyl coenzyme A (CoA)
and NADH from nonfermentable substrates (42). Further, we
propose that Adr1 also activates expression of ATS1.

Nonsense-mediated mRNA decay (NMD) is a highly conserved mRNA degradation pathway. Historically, NMD has
been thought of as an RNA surveillance system whose role is
to identify and rid cells of mRNA with premature termination
codons and thus prevents accumulation of potentially harmful
truncated proteins. However, more recently, it has become
apparent that the NMD pathway of Saccharomyces cerevisiae
has a second role regulating the decay of wild-type mRNAs.
Genome-wide transcription profiling has revealed that a significant number (estimated to be between 5 and 10%) of wildtype transcripts accumulate in yeast cells when the NMD pathway is inactivated (15, 28). These mRNAs that accumulate can
be direct NMD substrates or could accumulate as an indirect
consequence of inactivation of NMD. PPR1 and URA3
mRNAs represent examples of mRNAs that are directly and
indirectly affected by inactivation of the NMD pathway, respectively. PPR1 mRNA is an NMD substrate because it is
degraded more rapidly in cells with an active NMD pathway
than those in which the NMD pathway has been inactivated
(20). It encodes a transcription activator, and the genes activated by Ppr1 are up-regulated in cells with an inactive NMD
pathway (18, 27). For example, URA3 is regulated by Ppr1.
URA3 mRNA accumulates in cells with an inactive NMD pathway; however, URA3 mRNA has the same half-life in cells with
active and inactive NMD pathways (27). Thus, accumulation of
URA3 mRNA is due to increased transcription activation by
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TABLE 1. Yeast strains used in this study
Strain

Genotype

W303a
AAY320

MATa ade2-1 ura3-11 his3-11,15 trp1-1 leu2-3,112 can1-100
MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3,112 can1-100 upf1-⌬2
(URA3)
MAT␣ ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3,112 can1-100 ATS1::URA3
MATa ura3-1 his3-11,15 trp1-1 leu2-3,112 rpb1-1
MATa ura3-1 his3-11,15 trp1-1 leu2-3,112 rpb1-1 upf1-⌬2 (URA3)
MATa trp1-901 leu2-3,112 ura3-52 his3-200 gal4⌬ gal80⌬ GAL2-ADE2
LYS2::GAL1-HIS3 met2::GAL7-lacZ
MATa his3⌬1 leu2⌬0 met15⌬0 ura3⌬0 adr1::KanMX4
MATa his3⌬1 leu2⌬0 met15⌬0 ura3⌬0
MATa his3⌬1 leu2⌬0 met15⌬0 ura3⌬0 ppr1::KanMX4

AAY315
AAY334
AAY335
PJ69-4a
3575
BY4741
1569

MATERIALS AND METHODS
Yeast strains, plasmids, and media. The S. cerevisiae strains used in this study
are listed in Table 1. Unless otherwise stated, yeast strains were grown and
maintained by standard methods (4). Adr1 was repressed in YP medium with 8%
glucose (YP–8% glucose) and derepressed in YP medium containing 3% ethanol
and 1% D-glucose (YP-ethanol). Adr1p repression and derepression media were
made and used as described by Sloan et al. (39). YP medium with 2% galactose
(YP–2% galactose) was used for induction of Gal4. YP–2% galactose medium
was prepared according to a standard protocol (4). The plasmids for ADR1
overexpression, pRS314ADR1 (ADR1 TRP1 CEN6 ARSH4) and pMW5 (ADR1
TRP1 2), were generously provided by Elton T. Young. The plasmid for expression of ADR1 from a GAL10 promoter, pKD34 ( PGAL10-ADR1-TCYC1 TRP1
2), was generously provided by Kenneth Dombek. Plasmids were transformed
into yeast strains by the high-efficiency Li acetate method (11).
Measurement of mRNA accumulation and half-life. mRNA steady-state levels
and half-lives were measured as described by Kebaara et al. (19), with the
exception of ADR1 mRNA expressed from the GAL10 promoter. The half-life of
this mRNA was measured by first growing the cells in YP–2% galactose to
activate transcription of the GAL promoter and then repressing the GAL promoter in YP–2% glucose as described by Parker et al. (34). The PCR primer
pairs used for synthesis of DNA used for probe synthesis are in Table 2. Northern
blots were PhosphorImaged with a Storm PhosphorImager (Amersham Pharmacia Biotech, Inc., Piscataway, NJ). Analysis of mRNA levels was performed
with ImageQuant Software, version 5.1, (Amersham Pharmacia Biotech, Inc.,
Piscataway, NJ) and Microsoft Excel (Microsoft Corporation, Redmond, WA).
mRNA levels were normalized with ScR1 RNA, an RNA polymerase III transcript that is insensitive to NMD (29). mRNA half-lives were determined from
graphs of percent mRNA remaining versus time. The graphs were prepared with
SigmaPlot software, version 6.10 (SPSS Science, Chicago, IL). Steady-state

Source or reference

S. Wente
19
37
19
19
17
Research Genetics
Research Genetics
Research Genetics

mRNA levels and mRNA half-lives were averaged from a minimum of three
independent experiments.
Bioinformatics. Identification of potential transcription factor binding sites in
the ATS1 promoter region was performed with the Promoter Database of Saccharomyces cerevisiae (http://rulai.cshl.edu/SCPD). Genomic DNA sequences for
Saccharomyces paradoxus, Saccharomyces mikatae, and Saccharomyces bayanus
were obtained from the Saccharomyces Genome Sequencing at the Genome
Sequencing Center (http://genomeold.wustl.edu/projects/yeast/). BLASTN was
used to find the 5⬘ end of the ATS1 open reading frame (ORF) sequences in the
S. paradoxus, S. mikatae, and S. bayanus genomic sequences. Five hundred base
pairs of sequence upstream of the ATS1 ORF was recovered from all of the
Saccharomyces yeast strains and aligned with CLUSTALW (http://www.ebi.ac.uk
/clustalw/). The average n-fold increase for various mRNAs was obtained from
the Nonsense-Mediated mRNA Decay database (http://144.92.19.47/default
.htm) (28). A two-sided test was used to calculate P values for the all of data in
the Lelivelt and Culbertson database with the null hypothesis that the mean
transcript abundances of a particular gene are equal in the knockout and wildtype samples and the alternative hypothesis that the transcript abundances are
not equal.

RESULTS
Steady-state ATS1 mRNA levels are elevated in Upf1p-deficient cells, but the ATS1 mRNA half-life is the same in UPF1
and upf1⌬ cells. ATS1 mRNA is one of the several hundred
mRNAs that accumulate in S. cerevisiae when the NMD pathway is inactivated (28). Northern blot analysis confirmed that

TABLE 2. Primer pairs used for probe DNA synthesis
Probe DNA

Primers

Source

ATS1

5⬘-d(TCT AAT GGG CAA AGG CAA CT)
5⬘-d(CCA AAC ACG CGA GGT TTT)

Operon, Inc.a

CYH2

5⬘-d(CAC TAA GAC TAG AAA GCA CAG AGG)
5⬘-d(GTA TTG GTC TCT CTT GTC TTC TGG G)

Operon, Inc.

ScR1

5⬘-d(GGC TGT AAT GGC TTT CTG GTG G)
5⬘-d(GGT TCA GGA CAC ACT CCA TCC)

Operon, Inc.

GAL4

YPL248C-F, YPL248C-R

Resgen, Inc.b

ADR1

5⬘-d(GGA TCC TAA TAC GAC TCA CTA TAG GGC TTC TTG TAT TGG CAG)
5⬘-d(ATG GCT AAC GTA GAA AAA CC)

Operon, Inc.

ADH2

YMR303C-F, YMR303C-R

Resgen, Inc.

GAL1

YBR020W-F, YBR020W-R

Resgen, Inc.

a
b

Alameda, CA.
Huntsville, AL.
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FIG. 1. The increase in ATS1 mRNA accumulation seen in upf1⌬
yeast strains relative to UPF1 yeast strains is an indirect effect of
inactivation of the NMD pathway. (A) Representative Northern blot
prepared with total RNAs from W303a (ATS1 UPF1), AAY320 (ATS1
upf1⌬), and AAY315 (ats1⌬ UPF1). The Northern blots were hybridized with radiolabeled ATS1 (top), CYH2 (middle), and ScR1 (bottom)
DNA probes. CYH2 and ScR1 are controls. CYH2 is a control for the
NMD phenotype of the yeast strains. The CYH2 probe detects both
CYH2 pre-mRNA and mRNA. CYH2 pre-mRNA is inefficiently
spliced, and consequently a significant amount of this pre-mRNA is
exported to the cytoplasm. CYH2 pre-mRNA has an in-frame stop
codon within its intron that targets it for NMD, while CYH2 mRNA is
not an NMD target (14). ScR1 is an RNA polymerase III transcript
that is not degraded by NMD (29). It was used as a loading control.
The relative ATS1 mRNA levels in UPF1 and upf1⌬ yeast cells are
shown below the corresponding bands in the top part of panel A.
(B) Determination of ATS1 mRNA half-life by Northern blot analysis
of total RNA harvested from isogenic yeast strains AAY334 (UPF1,
upper image) and AAY335 (upf1⌬, lower image) at the indicated time
points (in minutes) following arrest of transcription. Blots were hybridized with radiolabeled ATS1 DNA and PhosphorImaged. The halflives (T1/2, minutes) are the averages of at least three independent
experiments and were determined from a plot of percent mRNA
remaining versus time. Percent mRNA remaining was calculated by
dividing the number of pixels contained in a particular band by the
number of pixels contained in the first time point. The half-life of
ATS1 mRNA in each yeast strain is to the right of the PhosphorImages.

ATS1 mRNA levels are elevated in upf1⌬ cells relative to an
isogenic UPF1 strain (Fig. 1A). ATS1 mRNA accumulation is
1.9-fold ⫾ 0.3-fold higher in upf1⌬ cells than in isogenic UPF1
cells. No hybridization to RNA isolated from an ATS1⌬ strain
was seen. This strain lacks the ATS1 gene and is thus unable to
synthesize ATS1 mRNA. This confirms that the correct mRNA
was detected on the Northern blots. We conclude that NMD
affects ATS1 mRNA accumulation.
The NMD pathway can affect steady-state mRNA levels

EUKARYOT. CELL

either directly or indirectly. Directly affected mRNAs are degraded by the NMD pathway. These mRNAs have a shorter
half-life in yeast cells with a functional NMD pathway than in
yeast cells with mutations in the UPF genes. Indirect effects on
mRNA accumulation result when transcription of the gene
encoding the mRNA is regulated by the product of another
mRNA that is affected by the NMD pathway. Indirectly affected mRNAs have the same half-lives in yeast cells with a
functional NMD pathway as yeast cells with mutations in the
UPF genes. To determine if ATS1 mRNA is a direct or indirect
target of NMD, we compared ATS1 mRNA half-lives in isogenic UPF1 and upf1⌬ yeast strains (Fig. 1B). The ATS1
mRNA half-life is 10.4 ⫾ 2.1 min in UPF1 cells and 11.6 ⫾ 1.9
min in upf1⌬ cells. ATS1 mRNA half-lives are not significantly
different in UPF1 and upf1⌬ strains. Therefore, ATS1 mRNA
is not a direct substrate of NMD. Rather, it accumulates as an
indirect consequence of inactivation of the NMD pathway.
Identification of putative transcription factors that regulate
ATS1 and are affected by NMD. Because ATS1 mRNA is not
degraded by the yeast NMD pathway, we hypothesized that
NMD affects the accumulation of an mRNA encoding an ATS1
transcription regulator. We developed a strategy to identify
ATS1 transcription regulators whose mRNAs are elevated in
upf mutants relative to UPF yeast cells. Our overall strategy
was to (i) map putative transcription factor binding sites in the
promoter region of ATS1, (ii) determine whether the putative
transcription factor binding sites are conserved in closely related Saccharomyces yeast strains, (iii) identify putative transcription factors of ATS1 whose mRNAs accumulate in NMD
mutants, (iv) test whether ATS1 is regulated by the candidate
transcription factors, and (v) determine if the transcription
factor mRNA is directly or indirectly affected by NMD.
Putative transcription factors of ATS1 were identified by
analyzing the 500 bp upstream of the ATS1 ORF for putative
transcription factor binding sites with the Promoter Database
of Saccharomyces cerevisiae (http://rulai.cshl.edu/SCPD).
There are 13 putative binding sites for nine transcription factors in the ATS1 promoter region (Fig. 2A).
Potential transcription factor binding sites can also be identified by alignment of orthologous promoter regions from
closely related Saccharomyces strains (8, 21). We aligned the
sequences of the ATS1 promoter regions from S. cerevisiae, S.
paradoxus, S. mikatae, and S. bayanus with ClustalW (http:
//www.ebi.ac.uk/clustalw/). The binding sites for four transcription factors, Adr1, Gcr1, SCB, and Gal4, are conserved in the
ATS1 promoter (Fig. 2B). Thus, ATS1 may be regulated by
Adr1, Gcr1, SCB, and/or Gal4. Additional conserved sequences were observed, suggesting that ATS1 has additional
transcription factor binding sites. This result is not surprising
since the binding sites for only ⬃40% of the S. cerevisiae
transcription factors are known (26).
To determine whether Adr1, Gcr1, SCB, or Gal4 might be
regulated by NMD, we identified their genes and then found
the average n-fold increase calculated from high-density oligonucleotide arrays for the corresponding mRNAs (Table 3; 28;
http://144.92.19.47/default.htm). The average n-fold increase is
a measure of mRNA levels in upf mutant strains relative to
UPF yeast strains. The average GAL4 mRNA increase was
3.51-fold, indicating that this mRNA was elevated in NMD-
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FIG. 2. Potential transcription factor binding sites in the ATS1 promoter region. (A) Schematic diagram of the putative transcription factor
binding sites in the 500 bp upstream of the ATS1 ORF identified with the Promoter Database of Saccharomyces cerevisiae (http://rulai.cshl.edu
/SCPD). The FUN30 ORF is on the opposite strand of the ATS1 ORF, and its position relative to putative transcriptional activator binding sites
is indicated. (B) Comparison of the ATS1 promoter regions from S. cerevisiae, S. paradoxus, S. mikatae, and S. bayanus. The conserved potential
binding sites in the ATS1 promoter region for Adr1, Gcr1, SCB, and Gal4 are shaded.

2070
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TABLE 3. Summary of potential transcription factor binding sites in the ATS1 promoter region and effect of inactivation of NMD on
accumulation of their mRNAs
Transcription
factora

Consensus binding sitea

Location of putative binding site
in ATS1 promoter regiona

Transcription factor
gene(s)b

Avg increasec
(n-fold)

Relative mRNA
accumulation (upf1⌬/
UPF1)d

GCR1

CATCC

⫺421 to ⫺417, ⫺334 to ⫺330

GCR1

1.08

NDe

ADR1

TCTCC

⫺389 to ⫺385, ⫺365 to ⫺361

ADR1

1.20

2.6 ⫾ 0.21

SCB

CGCGAAA

⫺108 to ⫺102

SW14
SW16

0.95
0.96

ND

GAL4

CGGGGGTAACGCAGCCG

⫺97 to ⫺81

GAL4

3.51

2.9 ⫾ 0.21

a

Potential transcription factor binding sites in ATS1 were identified by using the Promoter Database of Saccharomyces cerevisiae (http://rulai.cshl.edu/SCPD) and
conserved in closely related Saccharomyces yeast strains.
b
The genes encoding the putative transcription factors of ATS1 were identified by using the Saccharomyces Genome Database (http://www.yeastgenome.org/).
c
The average n-fold increase in the corresponding mRNAs from each gene was calculated from high-density oligonucleotide arrays (28; http://144.92.19.47
/default.htm).
d
Relative mRNA accumulation was determined by quantitative Northern blot analysis of RNAs obtained from isogenic W303a (UPF1) and AAY320 (upf1⌬) yeast
strains. Values represent average data ⫾ the standard deviation calculated from a minimum of three independent experiments. All mRNA levels were normalized to
ScR1, an RNA polymerase III transcript. In all cases, total RNA from null yeast strains was used as a control to confirm that we quantified the correct band.
e
ND, not determined.

deficient strains. The average increase in ADR1 mRNA was
1.20-fold, suggesting that this mRNA might be slightly elevated
in NMD-deficient cells (Table 3). The GCR1 mRNA and the
mRNAs encoding the subunits of SCB do not seem to accumulate in NMD mutants (Table 3). Further, the mRNA levels
of the genes regulated by Gcr1 and SCB are similar in wildtype and NMD-deficient cells (data not shown). Gcr1 and SCB
were not examined further.
GAL4 and ADR1 mRNAs accumulate in upf1⌬ cells relative
to UPF1 cells. Steady-state ADR1 and GAL4 mRNA levels in
upf1⌬ and UPF1 yeast strains were determined by Northern
blot analysis (Fig. 3). Both GAL4 and ADR1 mRNAs accumulate to higher levels in upf1⌬ cells than in UPF1 cells. Two
GAL4-specific bands of 2.9 and 1.8 kb were observed on the
Northern blots (Fig. 3A). These bands are specific for GAL4
because they were not present in the lane containing RNA
from a gal4 deletion strain. The expected size of the GAL4
mRNA is 2.8 kb (25). Thus, the upper band is the expected size
of the GAL4 mRNA and the lower band is a truncated GAL4
transcript. The lower band was not characterized further. The
full-length GAL4 mRNA accumulation was 2.9-fold ⫾ 0.2-fold
higher in upf1⌬ cells than in UPF1 cells. ADR1 mRNA also
accumulated to higher levels in upf1⌬ cells than in UPF1 cells
(Fig. 3B). We found a 2.6-fold ⫾ 0.2-fold higher level of ADR1
mRNA accumulation in upf1⌬ cells compared to UPF1 cells
(Fig. 3B). Thus, transcription activation of ATS1 by Gal4p
and/or Adr1p could account for the increased ATS1 mRNA
accumulation in upf1⌬ cells. For this reason, we tested whether
Gal4p and Adr1p regulate ATS1.
The NMD-dependent increase in GAL4 mRNA does not
account for the accumulation of ATS1 mRNA in upf1⌬ cells.
Gal4 is a transcription activator for genes controlling the metabolism of galactose and galactose disaccharides such as lactose (reviewed in reference 6). Gal4-dependent transcription
of these genes is activated by galactose and strongly repressed
by glucose. Thus, we expect the mRNA levels for Gal4-regulated genes to be higher in YP–2% galactose-grown cells than
in YP–2% glucose-grown cells. To test if Gal4 controls ATS1
transcription, the effects of changes in Gal4 expression on

ATS1 mRNA levels were compared (Fig. 4). We determined
steady-state ATS1 mRNA levels in UPF1 GAL4 and upf1⌬
GAL4 yeast cells grown in YP–2% galactose and YP–2% glucose. Steady-state ATS1 mRNA levels were 1.0-fold ⫾ 0.0-fold
and 0.4-fold ⫾ 0.0-fold in UPF1 GAL4 yeast cells grown in
glucose- and galactose-containing media, respectively. ATS1
mRNA levels were 2.3-fold ⫾ 0.4-fold higher in upf1⌬ cells
than in UPF1 cells grown in glucose and 1.9-fold ⫾ 0.2-fold
higher in upf1⌬ cells than in UPF1 cells grown in galactose
(Fig. 4). As a control, we examined GAL1 mRNA levels in cells
grown in YP–2% galactose and YP–2% glucose. GAL1 is a
Gal4-regulated gene (6). As expected, GAL1 mRNA was undetectable in cells grown in YP–2% glucose and readily detectable in YP–2% galactose. Thus, we conclude that ATS1
mRNA does not increase under conditions that activate Gal4.
We also tested whether ATS1 mRNA levels were affected by
loss of Gal4 function by examining ATS1 mRNA levels in
GAL4 and gal4⌬ yeast strains. ATS1 mRNA accumulation was
1.0-fold ⫾ 0.0-fold and 0.7-fold ⫾ 0.0-fold in GAL4 and gal4⌬
yeast strains, respectively (Fig. 4). Thus, loss of GAL4 function
causes a small decrease in ATS1 expression.
Based on these results, we conclude that Gal4 is probably
not a transcription activator of ATS1 because ATS1 expression
is not activated under conditions that activate Gal4 and loss of
Gal4 results in only a small decrease in ATS1 expression. Thus,
the NMD-dependent increase in GAL4 mRNA does not account for the accumulation of ATS1 mRNA in upf1⌬ cells. We
have not examined the basis of the Upf1p-dependent increase
in GAL4 mRNA further.
Adr1 may be an ATS1 transcription regulator. The potential
regulation of ATS1 by Adr1p was tested in two ways. First,
steady-state ATS1 mRNA levels were determined for strains
differing only in their ADR1 gene copy numbers (Fig. 5A).
Second, steady-state ATS1 mRNA levels were determined in
yeast strains grown under conditions that repress and derepress Adr1, respectively (Fig. 5B).
If Adr1 regulates ATS1, we expect ATS1 mRNA levels to
increase in cells overexpressing ADR1 and decrease in adr1⌬
cells because they lack Adr1. The ADR1 gene copy number was
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FIG. 4. ATS1 expression is not increased under conditions that
activate Gal4p. Shown is a representative Northern blot prepared with
total RNAs from W303a (UPF1) and AAY320 (upf1⌬) grown in YP
with 2% glucose (YP-2% glu) or 2% galactose (YP-2% gal) and from
PJ69-4a (gal4⌬) grown in glucose. The Northern blots were hybridized
with radiolabeled ATS1, GAL1, and ScR1 probes. The relative ATS1
mRNA levels are shown below the corresponding bands in the top
panel.

FIG. 3. GAL4 and ADR1 mRNAs accumulate in upf1⌬ cells relative to UPF1 cells. Representative Northern blots were prepared with
total RNAs from W303a (UPF1), AAY320 (upf1⌬), PJ69-4a (gal4⌬),
and Research Genetics strain 3573 (adr1⌬). The Northern blots were
hybridized with radiolabeled GAL4 or ADR1 and CYH2 and ScR1
DNAs. The relative GAL4 and ADR1 mRNA levels in UPF1 and upf1⌬
yeast cells are shown below the corresponding bands.

increased by transforming W303a (ADR1) with an ADR1 centromeric plasmid (Fig. 5A). As a control, ADR1 mRNA accumulation was determined. ADR1 mRNA accumulation is 4.1fold ⫾ 0.1-fold higher in cells with additional copies of the
ADR1 gene on a centromeric plasmid than in an isogenic
ADR1 yeast strain which only expressed ADR1 from its normal
chromosomal location (Fig. 5A). Thus, we see an increase in
ADR1 expression when the ADR1 gene copy number increases.
ATS1 mRNA accumulation is 4.0-fold ⫾ 1.5-fold higher in cells
transformed with the ADR1 gene on a centromeric plasmid
than in an isogenic yeast strain expressing only the chromosomal copy of ADR1 (Fig. 5A). The effect of loss of Adr1

function on steady-state ATS1 mRNA levels were determined
by measuring ATS1 mRNA levels in isogenic ADR1 and adr1⌬
cells grown under Adr1-derepressing conditions (YP–3% ethanol–1% D-glucose; Fig. 5B). The relative ATS1 mRNA abundance was 0.65-fold ⫾ 0.05-fold lower in adr1⌬ cells than in the
isogenic ADR1 cells.
If Adr1 regulates ATS1, we expect ATS1 mRNA levels to be
higher under conditions that derepress Adr1 and lower under
conditions that repress Adr1. Sloan et al. (39) showed that
Adr1 is derepressed in cells in ethanol (YP–3% ethanol–1%
D-glucose) and is repressed in cells grown in high glucose
(YP–8% glucose; note that standard yeast growth medium
contains 2% glucose). As a control for repression and derepression of Adr1, we examined ADH2 mRNA accumulation in
cells grown under derepressing and repression conditions, respectively (Fig. 5B). Adr1 positively regulates ADH2 by binding its promoter (10). ADH2 mRNA levels were difficult to
detect in RNA prepared from cells grown under repressing
conditions and readily detectable in RNA prepared from cells
grown under derepressing conditions (Fig. 5B). The accumulation of ATS1 mRNA in ADR1 cells grown under derepressing
and repressing conditions was measured by quantitative Northern blot analysis (Fig. 5B). ATS1 mRNA accumulation is 6.8fold ⫾ 2.0-fold higher in ADR1 cells grown under derepressing
conditions than in ADR1 cells grown under repressing conditions.
Thus, ATS1 mRNA levels increase when ADR1 expression
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FIG. 5. Adr1 may be a transcription activator of ATS1. (A) Representative Northern blot prepared with total RNA from W303a transformed
with pRS314 (ADR1) and pRS314ADR1 (CEN-ADR1). The Northern blots were hybridized with radiolabeled ATS1, ADR1, and ScR1 DNA
probes. (B) Representative Northern blot prepared with total RNAs from W303a (UPF1), AAY320 (upf1⌬), 3575 (adr1⌬), and BY4741 (ADR1).
The left column of images are the result of hybridization to Northern-blotted total RNA extracted from cells cultured under repressing conditions
(YP–8% glucose [YP-8% glu]). The right column has images of hybridization to Northern blotted total RNA extracted from cells cultured under
derepressing conditions (YP–3% ethanol–1% D-glucose [YP-ethanol]). The Northern blots were hybridized with radiolabeled ATS1, ADH2, and
ScR1 DNA probes. Adr1 is a positive regulator of ADH2, so ADH2 mRNA levels are a control for repression and derepression of Adr1. The
relative mRNA levels are shown below the corresponding bands.

increases and when Adr1 is derepressed. ATS1 mRNA levels
decrease when Adr1 is absent or when it is repressed. These
results are consistent with Adr1 being a transcription activator
of ATS1.
Many of the mRNAs encoded by Adr1-regulated genes may
accumulate to higher levels in upf⌬ cells than in UPF cells.
Adr1 has been shown to bind the promoters of 14 genes (42,
43). We examined the average n-fold increase calculated from
high-density oligonucleotide arrays for the corresponding
mRNAs (Table 4; 28, http://144.92.19.47/default.htm). Eight of
the mRNAs have an average increase of 1.3-fold or greater,
suggesting that these mRNA might be slightly elevated in
NMD-deficient cells (Table 4). Four genes have an average
increase of equal to or less than 1.15-fold. The average n-fold
increase was not available for two of the genes. We confirmed
that the mRNA for one Adr1-regulated gene, CTA1, accumulates by quantitative Northern blotting. CTA1 mRNA accumulation is 2.9-fold ⫾ 0.5-fold higher in upf1⌬ cells compared to
that in UPF1 cells.
ADR1 mRNA accumulation depends on the proteins required for NMD. Initiation of nonsense mRNA decay depends
on Upf1p, Upf2p, and Upf3p. Single, double, and triple deletions of the UPF genes have essentially identical effects on
nonsense mRNA accumulation (3, 13). ADR1 mRNA accumulation depends on Upf1p (Fig. 3). We tested whether ADR1
mRNA accumulation also depends on Upf2p and Upf3p by
measuring steady-state ADR1 mRNA levels in UPF, upf1⌬,
upf2⌬, and upf3⌬ yeast strains (Fig. 6A). The steady-state
ADR1 mRNA levels were 2.1-fold ⫾ 0.1-fold and 1.8-fold ⫾
0.4-fold higher in upf2⌬ and upf3⌬ yeast cells relative to those

in UPF yeast cells. The increase in steady-state ADR1 mRNA
levels observed in upf2⌬ and upf3⌬ yeast cells is similar to the
increase in steady-state ADR1 mRNA levels observed in upf1⌬
yeast cells (2.1 ⫾ 0.4). Thus, ADR1 mRNA accumulation is
dependent on Upf2p and Upf3p, as well as Upf1p.
Nonsense mRNAs are degraded by deadenylation-independent decapping, followed by 5⬘33⬘ decay (32). Dcp1p and
Xrn1p are required for decapping and 5⬘33⬘ decay, respectively (5, 32). To determine if decapping and 5⬘33⬘ decay are
also required for ADR1 mRNA decay, we examined steadystate ADR1 mRNA levels in isogenic wild-type, dcp1⌬, and
xrn1⌬ yeast strains (Fig. 6B). Steady-state ADR1 mRNA levels
were 5.2-fold ⫾ 2.4-fold and 4.9-fold ⫾ 2.9-fold higher in
dcp1⌬ and xrn1⌬ cells, respectively, relative to wild-type cells.
Thus, ADR1 mRNA accumulation also depends on these same
decay activities because ADR1 mRNA accumulates in a decapping mutant and a 5⬘33⬘ exoribonuclease mutant.
Accumulation of ADR1 mRNA following arrest of RNA polymerase II transcription. ADR1 mRNA has two features that
could target this mRNA for NMD. First, the ADR1 start codon
is located in a suboptimal context for initiation of translation
and it is followed by an out-of-frame AUG in the optimal
context at ⫹83 with respect to the first base of the ORF.
Second, ADR1 mRNA has an unusually long 3⬘ untranslated
region (UTR) (420, 590, and 810 nucleotides; 7). A suboptimal
start codon context predisposes an mRNA for leaky scanning
of the ribosome past the translation initiation codon. NMD is
then triggered when termination occurs following initiation of
translation at a downstream, out-of-frame AUG (41). The S.
cerevisiae optimal start codon context is ANNAUGPuPuPu,
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TABLE 4. Average n-fold increases in mRNAs transcribed from promoters previously shown to bind Adr1 (42)a
Standard ADR1regulated gene name
(alias[es])

Systematic name

Gene product

Avg n-fold increase
(P value)a

ADH2

YMR303C

Alcohol dehydrogenase II

1.06 (0.55)

ACS1 (FUN44)

YAL054C

Acetyl-CoA synthetase

1.39 (0.64)

GUT1

YHL032C

Glycerol kinase

1.5 (0.22)

FDH2

YPL275Wb
YPL276Wb

NAD⫹-dependent formate dehydrogenase

1.3 (0.42)
1.82 (0.49)

CIT3

YPR001W

Citrate synthase

1.98 (0.40)

ICL2

YPR006C

2-Methylisocitrate lyase

1.31 (0.64)

ALD4

YOR374W

Aldehyde dehydrogenase

1.14 (0.86)

POX1 (FOX1)

YGL205W

Fatty acyl CoA oxidase

CTA1

YDR256C

Catalase A

1.86 (0.23)

POT1 (FOX3, POX3)

YIL160C

3-Oxoacyl-CoA thiolase

1.53 (0.62)

ADY2 (ATO1)

YCR010C

Transmembrane protein

1.15 (0.57)

GIP2

YER054C

Glc7-interacting protein

1.44 (0.73)

ETR1 (MRF1, MRF1⬘)

YBR026C

2-Enoyl thioester reductase

0.95 (0.91)

YIL057C

Hypothetical ORF

ADR1

YDR216W

NA

NA
1.20 (0.83)

a

Average n-fold increase are from Lelivelt and Culbertson (28). NA, not available. For comparison, the average fold increase and P value for ADR1 mRNA are
shown.
b
YPL275W and YPL276W comprise a continuous ORF in some S. cerevisiae strains but not in genomic reference strain S288C.

where N is any base and Pu is an A or a G. The ADR1 start
codon context is ACUAUGGCT. Further, the downstream
out-of-frame AUG at ⫹83 in the optimal context for initiation
of translation. The average UTR length (5⬘ plus 3⬘ UTRs) of
yeast mRNAs is 256 nucleotides (16). mRNAs with unusually
long 3⬘ UTRs are substrates for NMD (2, 33). Furthermore,
the ADR1 3⬘ UTR contains at least three potential downstream
sequence elements (DSEs). DSEs are thought to function with
premature translation termination to target mRNAs for NMD
(35). Termination of translation upstream of a DSE targets an
mRNA for NMD, while termination of translation downstream
of a DSE does not. We hypothesized that leaky scanning
and/or the unusually long ADR1 3⬘ UTR could make this
mRNA an NMD substrate.
To test the possibility that ADR1 mRNA could be a direct
target of the NMD pathway, we determined ADR1 mRNA
half-lives in upf1⌬ and UPF1 yeast cells. ADR1 mRNA levels
were determined following inhibition of RNA polymerase II.
RNA polymerase II was inhibited by shifting rpb1-1 cells to the
nonpermissive temperature or with thiolutin. rpb1-1 is a temperature-sensitive allele that encodes an RNA polymerase II
subunit. As a control, we examined CYH2 pre-mRNA levels
following inhibition of transcription (Fig. 7B; data not shown).
Both treatments effectively arrested transcription, judging by
the decrease in CYH2 pre-mRNA levels following arrest. Further, the CYH2 pre-mRNA levels decreased faster in the

UPF1 cells than in the upf1⌬ cells. This is consistent with
previously published work (14).
The pattern of ADR1 mRNA levels following arrest of transcription is unusual. Initially, an increase in ADR1 mRNA
levels lasting approximately 10 min in upf1⌬ cells and approximately 15 min in UPF1 cells was observed. The amount of
ADR1 mRNA then decreases with time. The half-lives are 42.3
⫾ 12.9 and 9.3 ⫾ 4.0 min in UPF1 and upf1⌬ cells, respectively.
Interestingly, the pattern of ADR1 mRNA levels in these experiments was independent of the method used to arrest transcription because the pattern of ADR1 mRNA levels was the
same when transcription was arrested with thiolutin (data not
shown). Thus, ADR1 mRNA appears to actually be degraded
faster in upf1⌬ cells than in UPF1 cells following arrest of
transcription by shifting rpb1-1 cells to the nonpermissive temperature or by treatment with thiolutin.
Transient inhibition of general mRNA transcription by either genetic or chemical means induces a general stress response (12). As a part of this response, the mRNA levels for a
subset of heat shock genes increase. Consistent with this, Adr1
is activated by growth in ethanol, which also induces stress
responses (1). To begin to examine the basis for ADR1 mRNA
accumulation in upf1⌬ cells, we determined the half-life of
ADR1 mRNA expressed from pKD34, which carries PGAL10ADR1-TCYC1 in upf1⌬ and UPF1 yeast cells (Fig. 7C). The
half-lives of the ADR1 mRNA expressed from this construct
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mentable carbon sources, including lactate (42). UPF1, UPF2,
and UPF3 are required for full respiratory competence (9). upf
mutants have a respiratory impairment because they grow
poorly on medium containing lactate as a nonfermentable carbon energy source at 18°C. This correspondence suggests that
altered Adr1 expression could account for the poor growth of
upf mutants on lactate-containing medium. We tested this possibility by plating yeast cells overexpressing ADR1 on CEN and
2 plasmids. As shown in Fig. 8, W303a cells transformed with
pMW5 (2-ADR1) grow slower on complete minimal medium
lacking tryptophan and containing lactate than W303a cells
transformed with pRS314. The reduced growth rate of
W303a(pMW5) was specific for lactate because these transformants grew at the same rate as W303a(pRS314) on complete
minimal medium lacking tryptophan and containing glucose.
The reduced growth rate of W303a(pMW5) was specific for
overexpression of ADR1 because lactate sensitivity was not
seen in Research Genetics strain 3575 (adr1⌬). Interestingly,
the upf1⌬ strain (AAY320) grew as well as the isogenic UPF1
strain (W303a) in these experiments.
DISCUSSION

FIG. 6. Wild-type ADR1 mRNA also accumulates in upf2⌬, upf3⌬,
dcp1⌬, and xrn1⌬ cells. (A) Steady-state ADR1 mRNA levels in
HFY1200 (UPF1 UPF2 UPF3; wild type), HFY870 (upf1⌬), HFY1300
(upf2⌬), and HFY861 (upf3⌬) yeast cells grown in YAPD. (B) Steadystate ADR1 mRNA levels in HFY1200 (wild type), HFY1067 (dcp1⌬),
and HFY1081 (xrn1⌬) cells grown in YAPD. The Northern blots were
prepared with total RNA and hybridized with ADR1, CYH2, and ScR1
DNA probes. The relative ADR1 mRNA levels are shown below the
corresponding bands.

are 3.8 ⫾ 0.1 and 3.7 ⫾ 0.1 min in upf1⌬ and UPF1 yeast cells,
respectively. We can eliminate leaky scanning as a mechanism
for targeting ADR1 mRNA for NMD because this mRNA has
the same half-life in upf1⌬ and UPF1 yeast cells and it contains
the ADR1 translation initiation codon in its native context.
However, we cannot distinguish targeting of ADR1 mRNA for
NMD by a long 3⬘ UTR from an NMD-dependent change in
ADR1 transcription because this mRNA lacks the long ADR1
3⬘ UTR (PGAL10-ADR1-TCYC1 has 34 bp of sequence downstream of the ADR1 ORF, followed by the CYC1 terminator).
Overexpression of ADR1 results in respiratory impairment.
Adr1 regulates genes involved in aerobic oxidation of nonfer-

We have used a bioinformatics-based strategy to investigate
a coregulated gene set. We have shown that NMD regulates
accumulation of ADR1 mRNA, which encodes a transcription
activator, and that Adr1 is probably a transcription activator of
ATS1. The NMD-dependent regulation of ADR1 mRNA is
physiologically significant because overexpression of ADR1
causes respiratory impairment. This strategy is significant because it allows us to classify the genes regulated by NMD into
functionally related sets, an important step toward understanding the role NMD plays in the normal functioning of yeast
cells. Further, this is a unique way to identify genes regulated
by transcription factors.
Adr1 is a transcription activator, and three lines of evidence
indicate that it activates expression of ATS1. (i) ATS1 has
conserved Adr1 binding sites in its promoter region (Fig. 2),
(ii) ATS1 mRNA levels correlate with ADR1 expression levels
(Fig. 5A), and (iii) conditions that affect Adr1 activity have a
corresponding effect on ATS1 mRNA levels (Fig. 5B). Our
results are consistent with a global localization analysis in
which intergenic microarrays were probed with DNA from
chromatin bound by Adr1. Hybridization to the intergenic region of ATS1 is 1.544-fold by Adr1-bound DNA relative to
background. This binding ratio may underestimate Adr1 binding to the ATS1 promoter because the putative Adr1 binding
sites in the promoter region overlap the FUN30 ORF. Thus,
only the Adr1-bound chromatin fragments that extend into the
intergenic region between the ATS1 and FUN30 ORFs would
hybridize to the DNA on the intergenic microarray. Based on
our results and the results of Tachibana et al. (40), we propose
that Adr1 activates ATS1 expression and that activation accounts, at least in part, for the UPF1-dependent effect on ATS1
mRNA accumulation.
Why might Adr1 regulate ATS1? In previous studies, Adr1
was shown to bind the promoters for 14 different genes involved in the generation of acetyl-CoA and NADH from nonfermentable substrates (42, 43; Table 4). We showed that
Ats1p interacts with Nap1p, a cytoplasmic protein that regu-
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FIG. 7. ADR1 mRNA accumulation following arrest of transcription. Northern blots were prepared with total RNAs harvested from isogenic
yeast strains AAY334 (UPF1) and AAY335 (upf1⌬) at the indicated time points (minutes) after inhibition of RNA polymerase II. AAY334 and
AAY335 carry rpb1-1, a temperature-sensitive allele coding for a component of RNA polymerase II. Transcription arrests rapidly in these strains
when they are shifted to the nonpermissive temperature. (A, B) PhosphorImages of a representative Northern blot hybridized with radiolabeled
ADR1 DNA (A) and then stripped and reprobed with radiolabeled CYH2 DNA (B). Essentially identical results were obtained in three
independent experiments where transcription was arrested by a temperature shift and in one experiment in which thiolutin was used to arrest
transcription. Inhibition of RNA polymerase II was effective in these experiments because CYH2 pre-mRNA levels decreased as expected following
transcription arrest (B). (C) PhosphorImages of a representative Northern blot prepared with RNAs from W303a and AAY320 transformed with pKD34,
which carries PGAL10-ADR1-TCYC1, and hybridized with radiolabeled ADR1 DNA. Percent mRNA remaining at each time point following inhibition of
transcription was calculated by dividing the amount of probe hybridized to a particular band (corrected for loading with ScR1) by the amount of probe
hybridized to the band at time zero. The percent mRNA remaining versus time after transcription inhibition was plotted with SigmaPlot.

lates the activity of the Cdc28p/Clb2p complex (38). Based on
these results, we proposed that the interaction between Ats1p
and Nap1p coordinates the microtubule state with the cell
cycle. Cell size changes during growth in different environments. For instance, cells grown in ethanol are larger than

glucose-grown cells (24). The increase in cell size seen in ethanol-grown cells is due to a delay in the cell cycle that is
partially mediated by the tyrosine kinase Swe1, a negative
regulator of the Cdc28-Clb complexes (24). Since Ats1p regulates the activity of the same complex, we propose that Adr1
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FIG. 8. Overexpression of ADR1 causes respiratory impairment.
The yeast strains used were W303a (UPF1 ADR1) transformed with
pRS314 (vector control), pRS314ADR1 (CEN-ADR1), and pMW5
(2-ADR1); AAY320 (upf1⌬) transformed with pRS314; BY4741
(ADR1); and Research Genetics strain 3575 (adr1⌬ in BY4741). The
strains were grown to an optical density at 260 nm of 0.4 to 0.6; diluted
100, 10⫺1, 10⫺2, and 10⫺3; spotted onto complete minimal medium
lacking tryptophan and containing either glucose (left panel) or lactate
(right panel); and incubated at 18°C.

regulates ATS1 as part of a mechanism to coordinate the cell
cycle with the metabolic status of the cell. If this is the case, we
predict that changes in ATS1 expression will have an effect on
cell size. Consistent with this prediction, deletion of ATS1
results in larger cells (23, 38).
Here we have shown that ADR1 mRNA accumulation is
regulated by NMD (Fig. 6). The NMD-dependent regulation
of ADR1 mRNA is physiologically relevant because overexpression of ADR1 mRNA may partially contribute to the respiratory impairment of upf mutants. We show that overexpression of ADR1 from a 2 plasmid causes respiratory
impairment (Fig. 8). Overexpression of ADR1 may only partially explain the respiratory impairment of upf mutants because ADR1 mRNA accumulation is 2.6-fold ⫾ 0.2-fold in a
upf1⌬ strain (Fig. 3B) and we did not see respiratory impairment until ADR1 was overexpressed from a 2 plasmid where
ADR1 mRNA levels were elevated 9.9-fold ⫾ 3.8-fold (data
not shown). Alternatively, deletion of the upf genes in the
strains used by de Pinto et al. (9) may have a more significant
impact on ADR1 expression than in the W303a background.
We have previously observed strain-dependent differences in
the accumulation of mRNAs degraded by the NMD pathway
(19). Future experiments will focus on determining whether
ADR1 regulation by NMD is direct or indirect.
Our strategy complements existing microarray analyses of
the effects of inactivation of NMD on global mRNA abundance in two ways. First, it allows us to sort the mRNAs
affected by NMD into physiologically relevant, coregulated
gene sets. Second, it uncovers low-abundance mRNAs at or
below the threshold of detection on microarrays. For example,
PPR1 mRNA is near the threshold of detection on microarrays
(28). Our approach is applicable to other coregulated gene
sets. Our strategy is limited to transcription factors with known
DNA binding sites. As binding sites are identified for additional transcription factors, we expect to be able to identify
additional NMD-regulated gene sets.
Several lines of evidence suggest that a role for NMD in the
regulation of decay of select wild-type mRNAs is not unique to
S. cerevisiae. Upf1 is essential for mammalian embryonic via-
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bility (30). NMD-deficient mouse embryos do not develop;
instead, they are resorbed shortly after implantation and
NMD-deficient blastocysts isolated at 3.5 days postcoitum
commit apoptosis after a brief period of growth. And in Caenorhabditis elegans, NMD deficiency causes minor morphogenic abnormalities of the genitalia and reduced brood size
(36). These effects probably reflect the failure both to rid the
cells of mRNAs with premature termination codons and to
down regulate natural substrates. As is seen in yeast, a significant percentage (4.9%) of physiologic transcripts are up-regulated mammalian cells depleted of Upf1 or Upf2 accumulate
(31). A representative subset of the up-regulated transcripts
with potential structural features that could cause premature
termination of translation had longer half-lives in Upf1-depleted cells. Furthermore, recently Kim et al. (22) showed that
mammalian Arf mRNA decay is dependent on Upf1 and Stau1,
but not Upf2 or Upf3X. Stau1 binds the 3⬘ UTR of Arf1
mRNA and reduces its abundance. This suggests at least that
mammalian Upf1 also functions in decay of wild-type mRNAs
that lack an apparent premature termination codon, a substrate reminiscent of the yeast PPR1 mRNA.
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